Skip to main content

Near-death experience

transpersonal effect

valencecontext-dependentfrequencyraretemporalacute

AI-inferred — this entry was drafted by AI and has not yet been verified against primary sources. A sourced revision is planned.

Near-death experience is a cluster of perceptual and cognitive phenomena in which a person believes they are dying or have died — commonly including out-of-body sensations, passage through darkness or toward light, encounter with a threshold or presence, and a conviction of imminent death.

As a drug effect it is acute and strongly dose-dependent, easing as the substance wears off; this distinguishes it from spontaneous phenomena reported in cardiac or physiological crises. It ranges from a fleeting sense of crossing a boundary to an overwhelming and apparently total dissolution.

Near-death experience is rare even among high-dose effects. It is most commonly induced at high doses under psychedelics such as psilocybin mushrooms and DMT, and under dissociatives such as ketamine. It also appears in a sudden and compressed form under hallucinogens such as Salvinorin A.

phenomenology

Near-death experience is felt as an encounter with finality: the ordinary sense of being alive and embodied is replaced by a conviction, held with unusual clarity, that death is imminent or has already occurred.

Attention withdraws from the physical body — which seems distant, unrecognizable, or absent — and fixes on an apparent threshold, presence, or expansive darkness. Calm and awe are common, though dread is equally possible; the two can alternate rapidly. Attending to the sense of departure tends to deepen it. At high doses under psychedelics or dissociatives, the encounter can extend into a complete erasure of personal identity.

mechanism

Near-death experience arises through different pathways depending on the drug class:

  • Psychedelics — act on 5-HT2A receptors, profoundly disrupting self-referential processing and the felt boundary between self and world; at high doses this can collapse into apparent ego dissolution and perceived death.
  • Dissociatives — block NMDA receptors, severing conscious awareness from the body and sensory input in a way that closely parallels the phenomenology of spontaneous near-death states.
  • Hallucinogens — Salvinorin A acts as a kappa-opioid receptor agonist, producing an abrupt and total disruption of bodily grounding experienced as sudden departure from the world.

How much each pathway contributes in a given case is not fully understood.

safety

Near-death experience is not itself life-threatening, but its intensity can make it indistinguishable from a genuine medical crisis, and it can trigger lasting psychological distress in unprepared people.

  • If it happens — remain still, breathe slowly, and ground yourself through touch or sound if possible; remind yourself the experience is substance-induced and will pass.
  • Seek help if — genuine cardiac symptoms appear — chest pain, irregular heartbeat, sustained loss of consciousness — or if disorientation persists well beyond the acute window.
  • Higher risk — people with a personal or family history of psychosis or dissociative disorders; the boundary between the drug effect and a clinical episode can blur. A trusted companion present throughout is strongly advised.

variability

Who experiences it, and how strongly, varies widely. It is confined almost entirely to high doses — at moderate doses, even under psychedelics or dissociatives, it is uncommon. Set and setting exert strong influence, especially under psychedelics, as do disposition and prior history with the substance.

Prior exposure to near-death or mystical accounts can shape the form the experience takes. Expectation interacts heavily: entering with anticipation or fear of death makes it more likely. A grounded, supported setting and familiarity with the substance tend to reduce intensity.

experience reports

No experience reports yet. Be the first to contribute.

First-person accounts of subjective effects, timing, and outcomes — submitted for harm reduction.

AI-generated · claude-sonnet-4-6 · reviewed

Harm-reduction reference — not medical advice.

Last updated May 25, 2026Report an issue